0001179110-15-016631.txt : 20151221
0001179110-15-016631.hdr.sgml : 20151221
20151221204146
ACCESSION NUMBER: 0001179110-15-016631
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151217
FILED AS OF DATE: 20151221
DATE AS OF CHANGE: 20151221
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC.
CENTRAL INDEX KEY: 0000927066
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 510354549
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
BUSINESS PHONE: 310-536-2668
MAIL ADDRESS:
STREET 1: 2000 16TH STREET
CITY: DENVER
STATE: CO
ZIP: 80202
FORMER COMPANY:
FORMER CONFORMED NAME: DAVITA INC
DATE OF NAME CHANGE: 20001005
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC
DATE OF NAME CHANGE: 19950524
FORMER COMPANY:
FORMER CONFORMED NAME: TOTAL RENAL CARE INC
DATE OF NAME CHANGE: 19940719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mildenberger Laura
CENTRAL INDEX KEY: 0001458379
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14106
FILM NUMBER: 151300595
MAIL ADDRESS:
STREET 1: 601 HAWAII ST.
CITY: EL SEGUNDO
STATE: CA
ZIP: 90245
4
1
edgar.xml
FORM 4 -
X0306
4
2015-12-17
1
0000927066
DAVITA HEALTHCARE PARTNERS INC.
DVA
0001458379
Mildenberger Laura
C/O DAVITA HEALTHCARE PARTNERS INC
2000 16TH STREET
DENVER
CO
80202
0
1
0
0
Chief People Officer
Common Stock
2015-12-17
4
M
0
7300
43.35
A
14110
D
Common Stock
2015-12-17
4
F
0
4645
68.13
D
9465
D
Common Stock
2015-12-17
4
S
0
1242
68.1333
D
8223
D
Common Stock
2015-12-17
4
M
0
2250
55.34
A
10473
D
Common Stock
2015-12-17
4
F
0
1828
68.13
D
8645
D
Common Stock
2015-12-17
4
S
0
198
68.15
D
8447
D
Stock Appreciation Rights
43.35
2015-12-17
4
M
0
7300
0.00
D
2014-04-13
2016-04-13
Common Stock
7300
0
D
Stock Appreciation Rights
55.34
2015-12-17
4
M
0
2250
0.00
D
2015-04-01
2017-12-18
Common Stock
2250
2250
D
Represents the weighted average sale price of $68.1333. The range of prices for the sale of these shares was $68.13 - $68.15, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
The Stock Appreciation Rights were granted on 4/13/2011 and 50% vested each on 4/13/2014 and 4/13/2015.
The Stock Appreciation Rights were granted on 12/18/2012 and 50% vested on 4/1/2015.
Arturo Sida, Attorney-in-Fact
2015-12-21